These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 29671255)
1. Randomized Controlled Study to Investigate the Effect of Topical Diquafosol Tetrasodium on Corneal Sensitivity in Short Tear Break-Up Time Dry Eye. Kaido M; Kawashima M; Shigeno Y; Yamada Y; Tsubota K Adv Ther; 2018 May; 35(5):697-706. PubMed ID: 29671255 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease. Mun Y; Kwon JW; Oh JY BMC Ophthalmol; 2018 Sep; 18(1):237. PubMed ID: 30185156 [TBL] [Abstract][Full Text] [Related]
3. The Effect of Topical Diquafosol Tetrasodium 3% on Dry Eye After Cataract Surgery. Baek J; Doh SH; Chung SK Curr Eye Res; 2016 Oct; 41(10):1281-1285. PubMed ID: 27049809 [TBL] [Abstract][Full Text] [Related]
4. Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye. Shimazaki-Den S; Iseda H; Dogru M; Shimazaki J Cornea; 2013 Aug; 32(8):1120-5. PubMed ID: 23635860 [TBL] [Abstract][Full Text] [Related]
5. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye. Tauber J; Davitt WF; Bokosky JE; Nichols KK; Yerxa BR; Schaberg AE; LaVange LM; Mills-Wilson MC; Kellerman DJ Cornea; 2004 Nov; 23(8):784-92. PubMed ID: 15502479 [TBL] [Abstract][Full Text] [Related]
6. Effects of eye drops containing a mixture of 3% diquafosol sodium and tocopherol acetate (vitamin E) on the ocular surface of murine dry eye. Li L; Jin R; Li Y; Yoon HS; Yoon HJ; Yoon KC Cutan Ocul Toxicol; 2021 Dec; 40(4):350-358. PubMed ID: 34496685 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial. Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K; Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038 [TBL] [Abstract][Full Text] [Related]
8. Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study. Lee KB; Koh KM; Kwon YA; Song SW; Kim BY; Chung JL Korean J Ophthalmol; 2017 Aug; 31(4):306-312. PubMed ID: 28752695 [TBL] [Abstract][Full Text] [Related]
9. Effect of diquafosol tetrasodium eye drop for persistent dry eye after laser in situ keratomileusis. Mori Y; Nejima R; Masuda A; Maruyama Y; Minami K; Miyata K; Amano S Cornea; 2014 Jul; 33(7):659-62. PubMed ID: 24858017 [TBL] [Abstract][Full Text] [Related]
10. Impact of Diquafosol Ophthalmic Solution on Tear Film and Dry Eye Symptom in Type 2 Diabetic Dry Eye: A Pilot Study. Zhang Q; Zhang H; Qin G; Wu Y; Song Y; Yang L; Yu S; He X; Moore JE; Moutari S; Palme C; Xu L; He W; Pazo EE J Ocul Pharmacol Ther; 2022 Mar; 38(2):133-140. PubMed ID: 35049373 [No Abstract] [Full Text] [Related]
11. Long-Term Topical Diquafosol Tetrasodium Treatment of Dry Eye Disease Caused by Chronic Graft-Versus-Host Disease: A Retrospective Study. Yamane M; Ogawa Y; Fukui M; Kamoi M; Uchino M; Saijo-Ban Y; Kozuki N; Mukai S; Mori T; Okamoto S; Tsubota K Eye Contact Lens; 2018 Nov; 44 Suppl 2():S215-S220. PubMed ID: 29280750 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Combined Tear Film Therapy in Patients with Evaporative Dry Eye with Short Tear Film Breakup Time. Kim YH; Kang YS; Lee HS; Choi W; You IC; Yoon KC J Ocul Pharmacol Ther; 2017 Oct; 33(8):635-643. PubMed ID: 28846481 [TBL] [Abstract][Full Text] [Related]
13. Changes in Human Tear Proteome Following Topical Treatment of Dry Eye Disease: Cyclosporine A Versus Diquafosol Tetrasodium. Ji YW; Kim HM; Ryu SY; Oh JW; Yeo A; Choi CY; Kim MJ; Song JS; Kim HS; Seo KY; Kim KP; Lee HK Invest Ophthalmol Vis Sci; 2019 Dec; 60(15):5035-5044. PubMed ID: 31800960 [TBL] [Abstract][Full Text] [Related]
14. Effects of diquafosol tetrasodium administration on visual function in short break-up time dry eye. Kaido M; Uchino M; Kojima T; Dogru M; Tsubota K J Ocul Pharmacol Ther; 2013; 29(6):595-603. PubMed ID: 23537148 [TBL] [Abstract][Full Text] [Related]
15. The Effect of Diquafosol Ophthalmic Solution on Clinical Parameters and Visual Function in Soft Contact Lens-Related Dry Eye. Ogami T; Asano H; Hiraoka T; Yamada Y; Oshika T Adv Ther; 2021 Nov; 38(11):5534-5547. PubMed ID: 34590267 [TBL] [Abstract][Full Text] [Related]
16. Relationship of Corneal Pain Sensitivity With Dry Eye Symptoms in Dry Eye With Short Tear Break-Up Time. Kaido M; Kawashima M; Ishida R; Tsubota K Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):914-9. PubMed ID: 26943154 [TBL] [Abstract][Full Text] [Related]
17. Tolerability of Diquas LX on tear film and meibomian glands findings in a real clinical scenario. Arita R; Fukuoka S; Kaido M PLoS One; 2024; 19(9):e0305020. PubMed ID: 39325761 [TBL] [Abstract][Full Text] [Related]
18. Immediate Effect of 3% Diquafosol Ophthalmic Solution on Tear MUC5AC Concentration and Corneal Wetting Ability in Normal and Experimental Keratoconjunctivitis Sicca Rat Models. Choi KE; Song JS; Kang B; Eom Y; Kim HM Curr Eye Res; 2017 May; 42(5):666-671. PubMed ID: 27791390 [TBL] [Abstract][Full Text] [Related]
19. The Efficacy of Diquafosol Ophthalmic Solution in Non-Sjögren and Sjögren Syndrome Dry Eye Patients Unresponsive to Artificial Tear. Jeon HS; Hyon JY J Ocul Pharmacol Ther; 2016 Sep; 32(7):463-8. PubMed ID: 27294831 [TBL] [Abstract][Full Text] [Related]
20. The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjögren's syndrome: a pilot study. Yokoi N; Kato H; Kinoshita S Eye (Lond); 2016 Jun; 30(6):857-64. PubMed ID: 27055679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]